Medicine. Stroke--tPA and the clinic.


Journal Article

Clinical trial results are not always rapidly incorporated into routine medical practice. This Policy Forum describes a variety of barriers that have impeded the more widespread use of thrombolytic therapy (tPA, tissue plasminogen activator) for selected patients with acute ischemic stroke. These barriers are not insurmountable but will require a concerted effort to overcome.

Duke Authors

Cited Authors

  • Marler, JR; Goldstein, LB

Published Date

  • September 19, 2003

Published In

Volume / Issue

  • 301 / 5640

Start / End Page

  • 1677 -

International Standard Serial Number (ISSN)

  • 1095-9203

Citation Source

  • Scopus